Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.

Inflammation influences cancer development and progression. An elevated platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor prognosis in several malignancies. Here, we quantify the prognostic impact of this biomarker.